Global Norovirus Diagnostics Market Research Report 2025

Publication ID:

PB505254571

Publication Date:

May 13, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Norovirus Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Norovirus diagnostics refer to the methods and procedures used to identify the presence of norovirus in clinical samples, environmental samples, or food samples. Norovirus is a highly contagious virus that causes acute gastroenteritis in humans. It is a common cause of outbreaks of vomiting and diarrhea, particularly in settings such as cruise ships, healthcare facilities, and restaurants.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Norovirus Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Norovirus Diagnostics.
The Norovirus Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Norovirus Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Norovirus Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
R-Biopharm
ELITechGroup
Danaher Corporation (Cepheid)
Meridian Bioscience
Eiken Chemical
Altona Diagnostics
CerTest Biotec
Elisabeth Pharmacon
Qiagen
Segment by Type
Rapid Test Kits
PCR Kits
ELISA Based Kits
Segment by Application
Hospitals
Diagnostics Labs
Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Norovirus Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Norovirus Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Rapid Test Kits
1.2.3 PCR Kits
1.2.4 ELISA Based Kits
1.3 Market by Application
1.3.1 Global Norovirus Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostics Labs
1.3.4 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Norovirus Diagnostics Market Perspective (2020-2031)
2.2 Global Norovirus Diagnostics Growth Trends by Region
2.2.1 Global Norovirus Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Norovirus Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Norovirus Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Norovirus Diagnostics Market Dynamics
2.3.1 Norovirus Diagnostics Industry Trends
2.3.2 Norovirus Diagnostics Market Drivers
2.3.3 Norovirus Diagnostics Market Challenges
2.3.4 Norovirus Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Norovirus Diagnostics Players by Revenue
3.1.1 Global Top Norovirus Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Norovirus Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Norovirus Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Norovirus Diagnostics Revenue
3.4 Global Norovirus Diagnostics Market Concentration Ratio
3.4.1 Global Norovirus Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Norovirus Diagnostics Revenue in 2024
3.5 Global Key Players of Norovirus Diagnostics Head office and Area Served
3.6 Global Key Players of Norovirus Diagnostics, Product and Application
3.7 Global Key Players of Norovirus Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Norovirus Diagnostics Breakdown Data by Type
4.1 Global Norovirus Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Norovirus Diagnostics Forecasted Market Size by Type (2026-2031)
5 Norovirus Diagnostics Breakdown Data by Application
5.1 Global Norovirus Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Norovirus Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Norovirus Diagnostics Market Size (2020-2031)
6.2 North America Norovirus Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Norovirus Diagnostics Market Size by Country (2020-2025)
6.4 North America Norovirus Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Norovirus Diagnostics Market Size (2020-2031)
7.2 Europe Norovirus Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Norovirus Diagnostics Market Size by Country (2020-2025)
7.4 Europe Norovirus Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Norovirus Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Norovirus Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Norovirus Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Norovirus Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Norovirus Diagnostics Market Size (2020-2031)
9.2 Latin America Norovirus Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Norovirus Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Norovirus Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Norovirus Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Norovirus Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Norovirus Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Norovirus Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Norovirus Diagnostics Introduction
11.1.4 Abbott Revenue in Norovirus Diagnostics Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 R-Biopharm
11.2.1 R-Biopharm Company Details
11.2.2 R-Biopharm Business Overview
11.2.3 R-Biopharm Norovirus Diagnostics Introduction
11.2.4 R-Biopharm Revenue in Norovirus Diagnostics Business (2020-2025)
11.2.5 R-Biopharm Recent Development
11.3 ELITechGroup
11.3.1 ELITechGroup Company Details
11.3.2 ELITechGroup Business Overview
11.3.3 ELITechGroup Norovirus Diagnostics Introduction
11.3.4 ELITechGroup Revenue in Norovirus Diagnostics Business (2020-2025)
11.3.5 ELITechGroup Recent Development
11.4 Danaher Corporation (Cepheid)
11.4.1 Danaher Corporation (Cepheid) Company Details
11.4.2 Danaher Corporation (Cepheid) Business Overview
11.4.3 Danaher Corporation (Cepheid) Norovirus Diagnostics Introduction
11.4.4 Danaher Corporation (Cepheid) Revenue in Norovirus Diagnostics Business (2020-2025)
11.4.5 Danaher Corporation (Cepheid) Recent Development
11.5 Meridian Bioscience
11.5.1 Meridian Bioscience Company Details
11.5.2 Meridian Bioscience Business Overview
11.5.3 Meridian Bioscience Norovirus Diagnostics Introduction
11.5.4 Meridian Bioscience Revenue in Norovirus Diagnostics Business (2020-2025)
11.5.5 Meridian Bioscience Recent Development
11.6 Eiken Chemical
11.6.1 Eiken Chemical Company Details
11.6.2 Eiken Chemical Business Overview
11.6.3 Eiken Chemical Norovirus Diagnostics Introduction
11.6.4 Eiken Chemical Revenue in Norovirus Diagnostics Business (2020-2025)
11.6.5 Eiken Chemical Recent Development
11.7 Altona Diagnostics
11.7.1 Altona Diagnostics Company Details
11.7.2 Altona Diagnostics Business Overview
11.7.3 Altona Diagnostics Norovirus Diagnostics Introduction
11.7.4 Altona Diagnostics Revenue in Norovirus Diagnostics Business (2020-2025)
11.7.5 Altona Diagnostics Recent Development
11.8 CerTest Biotec
11.8.1 CerTest Biotec Company Details
11.8.2 CerTest Biotec Business Overview
11.8.3 CerTest Biotec Norovirus Diagnostics Introduction
11.8.4 CerTest Biotec Revenue in Norovirus Diagnostics Business (2020-2025)
11.8.5 CerTest Biotec Recent Development
11.9 Elisabeth Pharmacon
11.9.1 Elisabeth Pharmacon Company Details
11.9.2 Elisabeth Pharmacon Business Overview
11.9.3 Elisabeth Pharmacon Norovirus Diagnostics Introduction
11.9.4 Elisabeth Pharmacon Revenue in Norovirus Diagnostics Business (2020-2025)
11.9.5 Elisabeth Pharmacon Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Norovirus Diagnostics Introduction
11.10.4 Qiagen Revenue in Norovirus Diagnostics Business (2020-2025)
11.10.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Abbott
R-Biopharm
ELITechGroup
Danaher Corporation (Cepheid)
Meridian Bioscience
Eiken Chemical
Altona Diagnostics
CerTest Biotec
Elisabeth Pharmacon
Qiagen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂